Notably, studies affirm that the loss or malfunction of IKZF1 is closely linked to drug resistance, heightened relapse rates, and unfavorable prognosis in acute lymphocytic leukemia (ALL) and acute myeloid leukemia (AML) (30–32). The gene discussed is IKZF1; the disease is acute myeloid leukemia.